Tantbirojn Patou, Triratanachat Surang, Trivijitsilp Prasert, Niruthisard Somchai
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Rama IV Rd, Bangkok 10330, Thailand.
J Med Assoc Thai. 2008 Sep;91(9):1313-7.
To evaluate the hysterectomy specimen findings in the patients who underwent fractional curettage (F&C) with presence of adenocarcinoma in both endocervical and endometrial specimens.
Forty-one patients who had adenocarcinoma in both endocervical and endometrial specimens from F&C and underwent subsequent hysterectomy for surgical staging without pre-operative radiotherapy or chemotherapy at King Chulalongkorn Memorial Hospital between 1999 and 2007 were evaluated Histologic slides from both F&C and hysterectomy specimens were reviewed and assessed All cases of endometrial adenocarcinoma with cervical involvement (stage 2) in hysterectomy specimens were also assessed and compared to the results in F&C specimens.
Fifteen patients (36.6%) with both positive endocervical and endometrial specimens from F&C were diagnosed as endometrial adenocarcinoma within uterine cavity with lower uterine segment involvement. Only 34.1% of cases were endometrial carcinomas with cervical involvement. In the 35 cases with endometrial carcinoma stage 2, 60% had adenocarcinoma in both endocervical and endometrial specimens from F&C.
In the patients who had adenocarcinoma in both endocervical and endometrial specimens from fractional curettage, the most common final pathological diagnosis from hysterectomy specimens was endometrial adenocarcinoma within uterine cavity with lower uterine segment involvement. Therefore, only 60% of endometrial carcinoma stage 2 revealed positive adenocarcinoma in both endocervical and endometrial specimens from fractional curettage.
评估在宫颈管内膜和子宫内膜标本中均存在腺癌的情况下,接受分段刮宫术(F&C)的患者子宫切除标本的检查结果。
对1999年至2007年期间在朱拉隆功国王纪念医院接受分段刮宫术且宫颈管内膜和子宫内膜标本中均有腺癌、随后接受子宫切除术进行手术分期且未进行术前放疗或化疗的41例患者进行评估。对分段刮宫术和子宫切除标本的组织学切片进行复查和评估。对子宫切除标本中所有伴有宫颈受累的子宫内膜腺癌病例(2期)也进行评估,并与分段刮宫术标本的结果进行比较。
分段刮宫术宫颈管内膜和子宫内膜标本均为阳性的15例患者(36.6%)被诊断为子宫腔内子宫内膜腺癌伴子宫下段受累。仅有34.1%的病例为伴有宫颈受累的子宫内膜癌。在35例子宫内膜癌2期病例中,60%的患者分段刮宫术的宫颈管内膜和子宫内膜标本中均有腺癌。
对于分段刮宫术宫颈管内膜和子宫内膜标本中均有腺癌的患者,子宫切除标本最常见的最终病理诊断为子宫腔内子宫内膜腺癌伴子宫下段受累。因此,仅有60%的子宫内膜癌2期患者分段刮宫术的宫颈管内膜和子宫内膜标本中腺癌呈阳性。